CINCINNATI--(BUSINESS WIRE)--Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ:VIVO) today:
reported record first quarter net sales of $28,720,000, a 15% increase over the same period of the prior fiscal year;
reported record quarterly net earnings of $5,564,000, a 40% increase over the same period of the prior fiscal year;
reported record first quarter diluted per share earnings of $0.21, a 40% increase over the same period of the prior fiscal year;